ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,219.93
0.79%
Dow Jones
40,287.53
-0.93%
Gold vs US Dollar
2,406.11
0.22%
Brent Oil
81.525
-0.92%
Bitcoin
67,330.73
-1.21%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
22/07/202412:10PR Newswire (US)SynPlanet and SODA.Auto Forge a Game-Changing Partnership to Revolutionize Simulation Technology
22/07/202412:09Alliance NewsAlliance NewsIN BRIEF: Balanced Commercial Property sells London office holdingLSE:BCPTBalanced Commercial Property Trust Limited
22/07/202412:09PR Newswire (US)CAMTEK TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON THURSDAY, AUGUST 1, 2024NASDAQ:CAMTCamtek Ltd
22/07/202412:08PR Newswire (US)Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency
22/07/202412:08PR Newswire (US)Confronting the Preterm Birth Crisis: A New Hope on the Horizon
22/07/202412:07Alliance NewsAlliance NewsLONDON MARKET MIDDAY: European stocks unflustered by Biden withdrawal
22/07/202412:05PR Newswire (US)Goldco Awarded 'Best Customer Service' Award in Money Magazine's 2024 Best Gold IRA Company Reviews for the Second Consecutive Year
22/07/202412:05PR Newswire (US)Cyngn Regains Nasdaq Compliance and Confirms No Increase in Authorized SharesNASDAQ:CYNCYNGN Inc
22/07/202412:04UK RegulatoryMiton UK Microcap Trust Plc - Net Asset Value(s)LSE:MINIMiton Uk Microcap Trust Plc
22/07/202412:03PR Newswire (US)Gotcha Covered names David Dunsmuir President
22/07/202412:02PR Newswire (US)Tint World® named one of 2024's Best of the Best Franchises by Entreprenuer
22/07/202412:00UK RegulatoryMiddleGround Capital enters into Investment Agreement with STEMMER IMAGING AG and announces intention to launch a Voluntary Public Takeover Offer
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsTG:2HQTilray Brands Inc
22/07/202412:00UK RegulatoryMiddleGround Capital unterzeichnet Investmentvereinbarung mit STEMMER IMAGING AG und kündigt Absicht zur Abgabe eines freiwilligen öffentlichen Übernahmeangebots an
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsLSE:0Z6YTilray Inc
22/07/202412:00UK RegulatoryTilray Receives First New Cannabis Cultivation License in Germany Under New RegulationsXE:2HQTilray Brands Inc
22/07/202412:00Alliance NewsAlliance NewsIrish wholesale inflation speeds up to 2.8% annually in June
22/07/202412:00PR Newswire (US)Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
22/07/202412:00PR Newswire (US)The Cigna Group Foundation Launches Its Health Equity Impact FundNYSE:CICigna Group
22/07/202412:00PR Newswire (US)GLOBE LIFE INC. ANNOUNCES SECOND QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALLNYSE:GLGlobe Life Inc
22/07/202412:00PR Newswire (US)OMNICOM MEDIA GROUP AGENCIES OUTPERFORM FOR GROWTH ACROSS ALL FOUR REGIONSNYSE:OMCOmnicom Group Inc
22/07/202412:00PR Newswire (US)BIRKENSTOCK OPENS ITS VERY FIRST OWN RETAIL STORE IN FRANCE
22/07/202412:00PR Newswire (US)The Cigna Group Foundation Launches Its Health Equity Impact FundNYSE:CICigna Group
22/07/202412:00PR Newswire (US)Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
22/07/202412:00PR Newswire (US)Worldwide C-130J Super Hercules Fleet Soars Past 3 Million Flight HoursNYSE:LMTLockheed Martin Corp
22/07/202412:00PR Newswire (US)Cornerstone Capital Bank Adds Seven Senior Executives to Leadership Team
22/07/202412:00UK RegulatoryInvesco Global Equity Income Trust Plc - Net Asset Value(s)LSE:IGETInvesco Global Equity Income Trust Plc
22/07/202412:00PR Newswire (US)Group Therapy Can Respond to Mental Health Crisis with Increased Access to Services While Reducing Costs
22/07/202412:00PR Newswire (US)LSC Environmental Products Acquires Benzaco Scientific, Inc.
22/07/202412:00PR Newswire (US)OceanaGold Announces Share Buyback ProgramTSX:OGCOceanaGold Corporation

Your Recent History

LSE
GDR
Genedrive
LSE
BIRD
Blackbird
LSE
SOLG
Solgold
LSE
EZJ
Easyjet
LSE
TERN
Tern
LSE
JET2
Jet2
LSE
HUM
Hummingbird Resources
LSE
SCLP
Scancell
LSE
ENET
Ethernity Networks
LSE
PHNX
Phoenix
LSE
PPP
Pennpetro Energy
LSE
LLOY
Lloyds Banking
LSE
OCDO
Ocado
LSE
KEFI
Kefi Gold And Copper
LSE
UPL
Upland Resources
LSE
POS
Plexus
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved